CH635067A5 - Mercaptoacylamidobenzoylglycin und dessen salze sowie diese enthaltende pharmazeutische mittel. - Google Patents

Mercaptoacylamidobenzoylglycin und dessen salze sowie diese enthaltende pharmazeutische mittel. Download PDF

Info

Publication number
CH635067A5
CH635067A5 CH655278A CH655278A CH635067A5 CH 635067 A5 CH635067 A5 CH 635067A5 CH 655278 A CH655278 A CH 655278A CH 655278 A CH655278 A CH 655278A CH 635067 A5 CH635067 A5 CH 635067A5
Authority
CH
Switzerland
Prior art keywords
benzoyl
mercaptoacetylamino
glycine
salt
salts
Prior art date
Application number
CH655278A
Other languages
German (de)
English (en)
Inventor
Tellis Alexander Martin
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of CH635067A5 publication Critical patent/CH635067A5/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/10Expectorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CH655278A 1977-06-15 1978-06-15 Mercaptoacylamidobenzoylglycin und dessen salze sowie diese enthaltende pharmazeutische mittel. CH635067A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/806,877 US4093739A (en) 1977-06-15 1977-06-15 Mercaptoacylamidobenzoyl glycine and mucolytic process

Publications (1)

Publication Number Publication Date
CH635067A5 true CH635067A5 (de) 1983-03-15

Family

ID=25195031

Family Applications (1)

Application Number Title Priority Date Filing Date
CH655278A CH635067A5 (de) 1977-06-15 1978-06-15 Mercaptoacylamidobenzoylglycin und dessen salze sowie diese enthaltende pharmazeutische mittel.

Country Status (21)

Country Link
US (2) US4093739A (US08063081-20111122-C00044.png)
JP (1) JPS545933A (US08063081-20111122-C00044.png)
AU (1) AU520094B2 (US08063081-20111122-C00044.png)
BE (1) BE868114A (US08063081-20111122-C00044.png)
CA (1) CA1132607A (US08063081-20111122-C00044.png)
CH (1) CH635067A5 (US08063081-20111122-C00044.png)
DE (1) DE2825931A1 (US08063081-20111122-C00044.png)
DK (1) DK268478A (US08063081-20111122-C00044.png)
ES (1) ES470825A1 (US08063081-20111122-C00044.png)
FI (1) FI71307C (US08063081-20111122-C00044.png)
FR (1) FR2394526A1 (US08063081-20111122-C00044.png)
GB (1) GB2001958B (US08063081-20111122-C00044.png)
GR (1) GR73530B (US08063081-20111122-C00044.png)
IE (1) IE46995B1 (US08063081-20111122-C00044.png)
IT (1) IT1107483B (US08063081-20111122-C00044.png)
LU (1) LU79805A1 (US08063081-20111122-C00044.png)
NL (1) NL7806360A (US08063081-20111122-C00044.png)
PH (1) PH13512A (US08063081-20111122-C00044.png)
SE (1) SE441526B (US08063081-20111122-C00044.png)
YU (1) YU40195B (US08063081-20111122-C00044.png)
ZA (1) ZA783443B (US08063081-20111122-C00044.png)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296500A (en) * 1991-08-30 1994-03-22 The Procter & Gamble Company Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy
SE9103572D0 (sv) * 1991-11-29 1991-11-29 Astra Ab Organic salts of n,n'-diacetyl cystine
ES2148305T3 (es) * 1993-11-16 2000-10-16 Novartis Ag Derivados de aminoacidos ciclicos que tienen actividad inhibidora de ace y nep.
US5432186A (en) * 1993-11-16 1995-07-11 Ciba-Geigy Corporation Cyclic amino acid derivatives
US5451405A (en) * 1994-04-25 1995-09-19 Chesebrough-Pond's Usa Co. Skin treatment composition
JP3261969B2 (ja) * 1996-02-29 2002-03-04 豊田合成株式会社 ホースとその製造方法
US6294695B1 (en) * 1998-03-26 2001-09-25 Mount Sinai School Of Medicine Of The City University Of New York Aminobenzoic acid derivatives having anti-tumorigenic activity methods of making and using the same
US6797319B2 (en) * 2002-05-31 2004-09-28 Kimberly-Clark Worldwide, Inc. Application of foam to tissue products using a liquid permeable partition
FI3678739T3 (fi) 2017-09-07 2024-05-21 Childrens Hospital Philadelphia Koostumuksia ja menetelmiä periytyvän kystatiini c -amyloidiangiopatian (hccaa) ja muiden poikkeaviin amyloidikertymiin liittyvien hermostoa rappeuttavien häiriöiden hoitoon

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2520293A (en) * 1947-01-30 1950-08-29 Endo Products Inc Mercaptoacetanilide derivatives
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
US3663690A (en) * 1969-08-12 1972-05-16 Hoechst Co American Mucolytic composition and method of treatment of broncho-pulmonary disorders therewith
BE789811A (fr) * 1971-10-07 1973-04-06 Bristol Myers Co 1,4-bis-acylpiperazines
BE789838A (fr) * 1971-10-13 1973-02-01 Cerm Cent Europ Rech Mauvernay Nouveaux derives de la cysteine et leur application en therapeutique
FR2187327B1 (US08063081-20111122-C00044.png) * 1972-06-15 1975-06-20 Rech Pharm Scientifiques
US3971828A (en) * 1972-10-03 1976-07-27 Santen Pharmaceutical Co. Ltd. N-(mercaptoacyl)aminoacids
US3857951A (en) * 1973-09-14 1974-12-31 Cassenne Lab Sa Use of 2-mercaptopropionylglycine and its alkali metal salts in treating respiratory diseases
US4005222A (en) * 1975-05-21 1977-01-25 Mead Johnson & Company Mucolytic mercaptoacylamidobenzoic and benzenesulfonic acid compounds and process

Also Published As

Publication number Publication date
FR2394526B1 (US08063081-20111122-C00044.png) 1980-07-04
PH13512A (en) 1980-06-03
YU40195B (en) 1985-08-31
JPS6225657B2 (US08063081-20111122-C00044.png) 1987-06-04
CA1132607A (en) 1982-09-28
FI71307B (fi) 1986-09-09
GB2001958B (en) 1982-02-03
GB2001958A (en) 1979-02-14
US4132803A (en) 1979-01-02
DE2825931A1 (de) 1979-01-04
ZA783443B (en) 1979-06-27
DK268478A (da) 1978-12-16
IE46995B1 (en) 1983-11-30
US4093739A (en) 1978-06-06
IT1107483B (it) 1985-11-25
AU520094B2 (en) 1982-01-14
FR2394526A1 (fr) 1979-01-12
YU137578A (en) 1983-01-21
SE7806880L (sv) 1978-12-16
BE868114A (fr) 1978-12-14
NL7806360A (nl) 1978-12-19
FI781866A (fi) 1978-12-16
SE441526B (sv) 1985-10-14
LU79805A1 (fr) 1979-02-02
GR73530B (US08063081-20111122-C00044.png) 1984-03-12
ES470825A1 (es) 1979-10-01
AU3711278A (en) 1979-12-20
JPS545933A (en) 1979-01-17
IT7849864A0 (it) 1978-06-14
FI71307C (fi) 1986-12-19
DE2825931C2 (US08063081-20111122-C00044.png) 1987-01-29
IE781194L (en) 1978-12-15

Similar Documents

Publication Publication Date Title
DE2709820C2 (de) N-(Mercaptoacyl)-L oder DL-cysteine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende mucolytische Mittel
CH647527A5 (de) Salz von 1,1-dioxopenicillanoyloxymethyl-6-(d-alpha-amino-alpha-phenylacetamido)-penicillanat, verfahren zu dessen herstellung sowie dieses salz enthaltende pharmazeutische praeparate.
DE2362409C3 (de) N,N'-(m-Phenylen)-dioxamidsäuren und deren Derivate, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten
DE2446010A1 (de) 4-(monoalkylamino)benzoesaeurederivate und verfahren zu ihrer herstellung
US4096277A (en) Mucolytic mercaptoacylamidobenzamides and process of using same
EP0090195A1 (de) Neue quartäre 6,11-Dihydro-dibenzo-(b,e)-thiepin-11-N-alkyl-norscopinether und Verfahren zu deren Herstellung
DE3532081C2 (US08063081-20111122-C00044.png)
DE2165962C2 (de) 4-Hydroxy-6-arylpyrimidine
DE2527914A1 (de) Vincaminverbindungen, verfahren zu deren herstellung sowie diese enthaltende pharmazeutische mittel
EP0533790B1 (de) Neue salzform von 5-difluormethoxy-2- [3,4-dimethoxy-2-pyridyl)methylsulfinyl]-1h-benzimidazol
CH635067A5 (de) Mercaptoacylamidobenzoylglycin und dessen salze sowie diese enthaltende pharmazeutische mittel.
WO1982000293A1 (en) Substituted adenosine-3',5'-phosphobenzyl triester derivatives,method for their preparation and medicaments containing such compounds
DD284026A5 (de) Verfahren zur herstellung von estern
DE2411823A1 (de) Verwendung von 1,2,4-triazol-3-carboxamiden und -thiocarboxamiden als antivirenmittel
DE3212817C2 (US08063081-20111122-C00044.png)
DE1620629B2 (de) Verwendung eines Salzes von 2-Merkaptoäthansulfonsäure zur Herstellung von Mukolytica
DE2525250C2 (de) N,N'-Phenylendioxamsäureester, Verfahren zu deren Herstellung sowie pharmazeutische Präparate, die diese Verbindungen enthalten
DE2937532A1 (de) Hydroxamsaeureverbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2318784A1 (de) N-(2,4-dihydroxybenzoyl)-4-aminosalizylsaeure
DD158397A5 (de) Verfahren zur herstellung von isophthalsaeurepicolylamidmonohydrat
DD145266A5 (de) Verfahren zur herstellung von 6-methoxy-2-acetylnaphthalinoxim-derivaten
IE48351B1 (en) Novel l-cysteine derivatives and medicaments containing them
DE2305271A1 (de) Kristallines ammonium-n-acetyl-lcysteinat und verfahren zu dessen herstellung
DE3405172C2 (US08063081-20111122-C00044.png)
DE2361488C3 (de) Verwendung von Tri-n-propylessigsäurederivaten

Legal Events

Date Code Title Description
PL Patent ceased